Brainstorm Cell Therapeutics Inc.

BCLI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$187$1,300$772$18,856
Short-Term Investments$0$0$2,211$3,238
Receivables$63$51$91$0
Inventory$0$0$0$0
Other Curr. Assets$135$548$32$1,186
Total Curr. Assets$385$1,899$3,106$23,280
Property Plant & Equip (Net)$1,241$2,102$5,322$5,953
Goodwill$0$0$0$0
Intangibles$0$3$0$17
Long-Term Investments$184$185$0$0
Tax Assets$0$0$0$0
Other NC Assets$22$19$23$27
Total NC Assets$1,447$2,309$5,345$5,997
Other Assets$0$0$0$0
Total Assets$1,832$4,208$8,451$29,277
Liabilities
Payables$6,080$4,954$6,224$3,700
Short-Term Debt$549$603$1,427$1,461
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,349$2,243$1,149$1,156
Total Curr. Liab.$8,978$7,800$8,800$6,317
LT Debt$171$672$2,666$3,618
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$447$594$0$0
Total NC Liab.$618$1,266$2,666$3,618
Other Liabilities$0$0$0$0
Cap. Leases$720$672$4,093$5,079
Total Liabilities$9,596$9,066$11,466$9,935
Equity
Pref Stock$0$0$0$0
Common Stock$14$13$12$12
Retained Earnings-$226,636-$215,013-$197,821-$173,544
AOCI$0$0$0-$0
Other Equity$218,858$210,142$194,794$192,874
Total Equity-$7,764-$4,858-$3,015$19,342
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,832$4,208$8,451$29,277
Net Debt$533-$25$3,321-$13,777